Damora Therapeutics, Inc. (DMRA) stock
DMRANasdaqPharmaceutical PreparationsFiscal year ends December 31
$21.60−0.45 (-2.04%)
Close on Nov 13, 2026Market cap $1.34BP/E 5.4Yield 0.00%
Damora Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Damora Therapeutics's enterprise value was $894.81M on Nov 11, 2026, against $15.99M a year earlier. Over the last 5 years it ranged from -$216.64M to $1.22B, with a median of -$12.00M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $894.81M | +3801.8% |
| 2025 | Dec 31, 2025 | $22.93M | – |
| 2024 | Dec 31, 2024 | -$13.85M | – |
| 2023 | Dec 29, 2023 | -$24.66M | – |
| 2022 | Dec 30, 2022 | -$39.67M | – |
| 2021 | Dec 31, 2021 | -$25.60M | – |
| 2020 | Dec 31, 2020 | -$82.08M | – |
See a number that looks wrong?